American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Zacks Research Analysts Increase Earnings Estimates for Omnicom Group Inc. (NYSE:OMC)

Zacks Research Analysts Increase Earnings Estimates for Omnicom Group Inc. (NYSE:OMC)

Omnicom Group Inc. (NYSE:OMC – Free Report) – Investment analysts at Zacks Research upped their Q2 2024 earnings estimates for Omnicom Group in a research note issued to investors on Tuesday, May 7th. Zacks Research... More of this article »
Image about Quanta Services, Inc. (NYSE:PWR) Forecasted to Earn Q2 2024 Earnings of $1.23 Per Share

Quanta Services, Inc. (NYSE:PWR) Forecasted to Earn Q2 2024 Earnings of $1.23 Per Share

Quanta Services, Inc. (NYSE:PWR – Free Report) – Investment analysts at DA Davidson issued their Q2 2024 EPS estimates for Quanta Services in a research note issued to investors on Tuesday, May 7th. DA Davidson analyst... More of this article »
Image about HC Wainwright Reiterates Buy Rating for Pliant Therapeutics (NASDAQ:PLRX)

HC Wainwright Reiterates Buy Rating for Pliant Therapeutics (NASDAQ:PLRX)

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a research report issued on Tuesday, Benzinga reports. They presently have a $36.00 price objective... More of this article »
Image about Palantir Technologies (NYSE:PLTR) PT Raised to $20.00 at Deutsche Bank Aktiengesellschaft

Palantir Technologies (NYSE:PLTR) PT Raised to $20.00 at Deutsche Bank Aktiengesellschaft

Palantir Technologies (NYSE:PLTR – Get Free Report) had its price objective boosted by stock analysts at Deutsche Bank Aktiengesellschaft from $18.00 to $20.00 in a research report issued on Tuesday, Benzinga reports. The firm... More of this article »
Image about Model N (NYSE:MODN) Rating Reiterated by Needham & Company LLC

Model N (NYSE:MODN) Rating Reiterated by Needham & Company LLC

Model N (NYSE:MODN – Get Free Report)‘s stock had its “hold” rating restated by Needham & Company LLC in a research note issued on Tuesday, Benzinga reports. Several other research firms have also weighed... More of this article »
Image about Cloudflare (NYSE:NET) Rating Increased to Buy at DZ Bank

Cloudflare (NYSE:NET) Rating Increased to Buy at DZ Bank

Cloudflare (NYSE:NET – Get Free Report) was upgraded by stock analysts at DZ Bank from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday, MarketBeat reports. The brokerage... More of this article »
Image about National CineMedia (NASDAQ:NCMI) Lowered to “Sell” at StockNews.com

National CineMedia (NASDAQ:NCMI) Lowered to “Sell” at StockNews.com

StockNews.com downgraded shares of National CineMedia (NASDAQ:NCMI – Free Report) from a hold rating to a sell rating in a research note released on Wednesday morning. NCMI has been the subject of several other reports. B. Riley... More of this article »
Image about Lisa Utzschneider Sells 8,044 Shares of Integral Ad Science Holding Corp. (NASDAQ:IAS) Stock

Lisa Utzschneider Sells 8,044 Shares of Integral Ad Science Holding Corp. (NASDAQ:IAS) Stock

Integral Ad Science Holding Corp. (NASDAQ:IAS – Get Free Report) CEO Lisa Utzschneider sold 8,044 shares of Integral Ad Science stock in a transaction on Monday, May 6th. The shares were sold at an average price of $9.97, for... More of this article »
Image about Don Schena Sells 10,000 Shares of WideOpenWest, Inc. (NYSE:WOW) Stock

Don Schena Sells 10,000 Shares of WideOpenWest, Inc. (NYSE:WOW) Stock

WideOpenWest, Inc. (NYSE:WOW – Get Free Report) insider Don Schena sold 10,000 shares of the firm’s stock in a transaction on Friday, May 3rd. The shares were sold at an average price of $5.00, for a total transaction of... More of this article »
Image about Rajesh Pankaj Sells 650 Shares of InterDigital, Inc. (NASDAQ:IDCC) Stock

Rajesh Pankaj Sells 650 Shares of InterDigital, Inc. (NASDAQ:IDCC) Stock

InterDigital, Inc. (NASDAQ:IDCC – Get Free Report) CTO Rajesh Pankaj sold 650 shares of the firm’s stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $103.87, for a total transaction... More of this article »
Image about Barrington Research Weighs in on Henry Schein, Inc.’s Q2 2024 Earnings (NASDAQ:HSIC)

Barrington Research Weighs in on Henry Schein, Inc.’s Q2 2024 Earnings (NASDAQ:HSIC)

Henry Schein, Inc. (NASDAQ:HSIC – Free Report) – Analysts at Barrington Research reduced their Q2 2024 earnings estimates for shares of Henry Schein in a research report issued to clients and investors on Wednesday,... More of this article »
Image about Brokers Set Expectations for Henry Schein, Inc.’s Q2 2024 Earnings (NASDAQ:HSIC)

Brokers Set Expectations for Henry Schein, Inc.’s Q2 2024 Earnings (NASDAQ:HSIC)

Henry Schein, Inc. (NASDAQ:HSIC – Free Report) – Research analysts at William Blair reduced their Q2 2024 earnings per share estimates for Henry Schein in a report issued on Tuesday, May 7th. William Blair analyst B.... More of this article »
Image about Singular Research Comments on FSD Pharma Inc.’s Q1 2024 Earnings (CVE:HUG)

Singular Research Comments on FSD Pharma Inc.’s Q1 2024 Earnings (CVE:HUG)

FSD Pharma Inc. (CVE:HUG – Free Report) – Singular Research issued their Q1 2024 earnings per share estimates for FSD Pharma in a report issued on Tuesday, May 7th. Singular Research analyst B. Cook forecasts that the... More of this article »
Image about Q2 2024 Earnings Forecast for Novanta Inc. Issued By William Blair (NASDAQ:NOVT)

Q2 2024 Earnings Forecast for Novanta Inc. Issued By William Blair (NASDAQ:NOVT)

Novanta Inc. (NASDAQ:NOVT – Free Report) – Analysts at William Blair lowered their Q2 2024 earnings per share estimates for shares of Novanta in a note issued to investors on Tuesday, May 7th. William Blair analyst... More of this article »
Image about Q2 2024 Earnings Estimate for Stoke Therapeutics, Inc. Issued By Leerink Partnrs (NASDAQ:STOK)

Q2 2024 Earnings Estimate for Stoke Therapeutics, Inc. Issued By Leerink Partnrs (NASDAQ:STOK)

Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Analysts at Leerink Partnrs reduced their Q2 2024 earnings per share estimates for Stoke Therapeutics in a report released on Monday, May 6th. Leerink Partnrs analyst... More of this article »